We are live on ! Find out more
INDV icon

Indivior Pharmaceuticals
INDV

120 hedge funds and large institutions have $1.58B invested in Indivior Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 44 increasing their positions, 24 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,168% more call options, than puts

Call options by funds: $4.74M | Put options by funds: $374K

150% more funds holding in top 10

Funds holding in top 10: 4 → 10 (+6)

83% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 24

82% more capital invested

Capital invested by funds: $867M → $1.58B (+$711M)

16% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 32

12.45% more ownership

Funds ownership: 73.27% → 85.73% (+12%)

3% more funds holding

Funds holding: 116 → 120 (+4)

Holders
120
Holders Change
+4
Holders Change %
+3.45%
% of All Funds
1.58%
Holding in Top 10
10
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+150%
% of All Funds
0.13%
New
37
Increased
44
Reduced
24
Closed
32
Calls
$4.74M
Puts
$374K
Net Calls
+$4.37M
Net Calls Change
+$3.55M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$65.4M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$19.6M
3
State Street
State Street
Massachusetts
+$18.3M
4
MP
Mangrove Partners
Connecticut
+$18.2M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$16.9M

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$20.8M
2
UBS Group
UBS Group
Switzerland
-$13.3M
3
Jane Street
Jane Street
New York
-$10.6M
4
WAM
Weiss Asset Management
Massachusetts
-$4.43M
5
F1I
Fund 1 Investments
Puerto Rico
-$4.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
TSC
1
Two Seas Capital
New York
$168M +$478K +41,018 +0.4%
OCM
2
Oaktree Capital Management
California
$162M – – –
DM
3
Deerfield Management
New York
$156M – – –
Goldman Sachs
4
Goldman Sachs
New York
$141M +$13.9M +1,195,095 +14%
MAP
5
Madison Avenue Partners
New York
$117M +$1.52M +130,089 +2%
Vanguard Group
6
Vanguard Group
Pennsylvania
$83.9M +$11.8M +1,016,088 +22%
BlackRock
7
BlackRock
New York
$83.8M +$65.4M +5,617,001 +8,312%
RCMNY
8
Rubric Capital Management (New York)
New York
$68.5M +$13M +1,117,140 +32%
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$52.7M +$19.6M +1,686,628 +89%
Millennium Management
10
Millennium Management
New York
$50.1M +$10.8M +931,199 +38%
NM
11
Newtyn Management
New York
$38.4M +$11.1M +956,080 +58%
UBS Group
12
UBS Group
Switzerland
$35.2M -$13.3M -1,139,289 -32%
MP
13
Mangrove Partners
Connecticut
$33.5M +$18.2M +1,559,870 +219%
JFG
14
Jefferies Financial Group
New York
$32.5M +$8.26M +708,941 +48%
Barclays
15
Barclays
United Kingdom
$30.9M +$8.81M +756,579 +56%
SCM
16
Scopia Capital Management
New York
$24.4M -$2.57M -220,253 -12%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$23.2M +$16.9M +1,447,939 +1,123%
State Street
18
State Street
Massachusetts
$23.1M +$18.3M +1,570,341 New
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$22M +$9.63M +827,230 +124%
PHS
20
PFM Health Sciences
California
$20M +$2.28M +196,098 +17%
KAM
21
Krensavage Asset Management
New York
$14.4M +$106K +9,106 +0.9%
GJL
22
Gendell Jeffrey L
$12.6M +$2.91M +250,000 +41%
CAM
23
Claret Asset Management
Quebec, Canada
$11M -$10.9K -937 -0.1%
Northern Trust
24
Northern Trust
Illinois
$10.8M +$8.56M +735,164 New
AAP
25
Ardsley Advisory Partners
Connecticut
$10.7M +$1.16M +100,000 +16%
1
2 3 4 5

INDV Hedge Fund Activity: Q2 2025 in Review

120 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Indivior Pharmaceuticals (INDV) for Q2 2025, worth a combined $1.58B — up 82% from $867M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new INDV positions and 32 closed out — a net gain of 5 holders — while 44 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock, adding an estimated $65.4M. The largest seller was Susquehanna International Group, cutting an estimated $20.8M.

  • 120 institutional investors held Indivior Pharmaceuticals (INDV) as of Q2 2025, up from 116 in Q1 2025.
  • Funds reported $1.58B of Indivior Pharmaceuticals stock for Q2 2025, up 82% quarter-over-quarter.
  • 37 funds opened new Indivior Pharmaceuticals positions in Q2 2025 and 32 closed out, a net change of +5 holders.
  • The largest Indivior Pharmaceuticals buyer in Q2 2025 was BlackRock, an estimated $65.4M added.
  • The largest Indivior Pharmaceuticals seller in Q2 2025 was Susquehanna International Group, an estimated $20.8M sold.

Based on aggregated 13F filings for Q2 2025.